IP Library Granted Patent US 8,536,130
Granted Patent B2
US 8,536,130 · App. 12/850,208 · Granted Sep 17, 2013

Use of 1 phenyl-3-dimethylamino-propane compounds for treating neuropathic pain

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,536,130
App. No.
12/850,208
Granted
Sep 17, 2013
Kind
B2
Abstract

Use of 1-phenyl-3-dimethylaminopropane compounds for the production of medicaments for treating neuropathic pain, preferably polyneuropathic pain, also preferably diabetic neuropathic pain, more preferably diabetic peripheral neuropathic pain, and furthermore preferably for treating diabetic peripheral neuropathy.

Claims (8)

1. A method of treating polyneuropathic pain in a subject suffering therefrom, said method comprising administering to said subject an effective polyneuropathic pain inhibiting amount of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol

or a pharmaceutically acceptable salt thereof.

2. A method according to claim 1 , comprising administering a hydrochloride salt of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol.

3. A method according to claim 1 , wherein said polyneuropathic pain is diabetic polyneuropathic pain.

4. A method according to claim 1 , wherein said polyneuropathic pain is peripheral polyneuropathic pain.

5. A method according to claim 1 , wherein said polyneuropathic pain is peripheral diabetic polyneuropathic pain.

6. A method of treating diabetic polyneuropathy in a subject suffering therefrom, said method comprising administering to said subject a pharmacologically effective amount of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol

or a pharmaceutically acceptable salt thereof.